Chemoinformaics analysis of serotonin (5-hydroxytryptamine)
| Molecular Weight | 176.219 | nRot | 2 |
| Heavy Atom Molecular Weight | 164.123 | nRig | 10 |
| Exact Molecular Weight | 176.095 | nRing | 2 |
| Solubility: LogS | -1.208 | nHRing | 1 |
| Solubility: LogP | 0.683 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 10 |
| nHA | 2 | APOL | 27.7035 |
| nHD | 3 | BPOL | 12.0385 |
| QED | 0.647 |
| Synth | 2.13 |
| Natural Product Likeliness | 0.636 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.443 |
| HIA | 0.421 |
| CACO-2 | -4.925 |
| MDCK | 0.00000279 |
| BBB | 0.109 |
| PPB | 0.166766 |
| VDSS | 1.253 |
| FU | 0.746668 |
| CYP1A2-inh | 0.816 |
| CYP1A2-sub | 0.783 |
| CYP2c19-inh | 0.108 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.036 |
| CYP2c9-sub | 0.927 |
| CYP2d6-inh | 0.671 |
| CYP2d6-sub | 0.916 |
| CYP3a4-inh | 0.031 |
| CYP3a4-sub | 0.13 |
| CL | 11.054 |
| T12 | 0.878 |
| hERG | 0.088 |
| Ames | 0.283 |
| ROA | 0.925 |
| SkinSen | 0.885 |
| Carcinogencity | 0.063 |
| EI | 0.181 |
| Respiratory | 0.728 |
| NR-Aromatase | 0.723 |
| Antiviral | No |
| Prediction | 0.768068 |